Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines

Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines



Johnson & Johnson Comes to Strategic Agreement with Sail Biomedicines
Under the agreement, Johnson & Johnson would make total initial payments of $785 million, and has the exclusive option to acquire Sail for $2.58 billion.

Leave a Reply

Your email address will not be published. Required fields are marked *